Join
Live feed
·
INSIDERFilingvia Quantisnow
Arrowhead Pharmaceuticals Inc. logo

Director Cohen Matthew Gregory was granted 11,882 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ARWR· Arrowhead Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARWR (Arrowhead Pharmaceuticals Inc.) and more on Quantisnow.

Director Cohen Matthew Gregory was granted 11,882 shares (SEC Form 4) | Quantisnow